标题:Therapeutic application of mesenchymal stem cells in bone and joint diseases
作者:Liu,Y.;Wu,J.;Zhu,Y.;Han,J.
作者机构:[Liu, Y] Jinan Pediatric Research Institute, Qilu Children's Hospital of Shandong University, Jinan 250022, China;[ Wu, J] Key Laboratory for Biotech- 更多
通讯作者:Han, JX
通讯作者地址:[Han, JX]Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Key Lab Biotech Drugs, Minist Hlth, Jinan 250062, Peoples R China.
来源:Clinical and experimental medicine
出版年:2014
卷:14
期:1
页码:13-24
DOI:10.1007/s10238-012-0218-1
关键词:Mesenchymal stem cells (MSCs);Osteoarthritis (OA);Osteogenesis imperfecta (OI);Osteonecrosis of the femoral head (ONFH);Osteoporosis;Rheumatoid arthritis (RA)
摘要:Mesenchymal stem cells (MSCs), the non-hematopoietic progenitor cells, are multi-potent stem cells from a variety of tissues with the capability of self-renewal, proliferation, differentiation into multi-lineage cell types, as well as anti-inflammatory and immunomodulatory. These properties make MSCs an ideal source of cell therapy in bone and joint diseases. This review describes the advances of animal study and preliminary clinical application in the past few years, related to MSC-based cell therapy in the common bone and joint diseases, including osteoarthritis, rheumatoid arthritis, osteoporosis, osteonecrosis of the femoral head and osteogenesis imperfecta. It highlights the promising prospect of MSC in clinical application of bone and joint diseases.
收录类别:SCOPUS;SCIE
WOS核心被引频次:36
Scopus被引频次:35
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84895171384&doi=10.1007%2fs10238-012-0218-1&partnerID=40&md5=8cebc40e909b0a969ffcc82ebbeb7911
TOP